Denis Delval

Denis DELVAL currently serves as President and CEO of Ethypharm, a position held since October 2022. Prior to this role, Denis DELVAL was Chairman and CEO of LFB from December 2017 to September 2022, leading a biopharmaceutical group that specializes in plasma-derived products and recombinant proteins for critical and rare diseases. Denis DELVAL's extensive experience also includes a tenure as Senior Vice President for Southern Europe and later for Europe West-South at ALK from 2006 to 2017, and earlier roles at Fournier Pharma as General Manager and VP Global Marketing, Bayer in various senior marketing and sales positions, and product management at Janssen-Cilag and SmithKline Beecham. Academic credentials include a PhD in Pharmacy from Université de Pharmacie d'Amiens and Paris Descartes, an education in General Management from ESSEC Business School, and an AMP from INSEAD.